Market Overview:
The global hepatitis test solution market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The market growth is attributed to the increasing prevalence of hepatitis infections, rising demand for rapid and accurate diagnostic tests, and growing awareness about the benefits of early diagnosis and treatment. Based on technology, the global hepatitis test solution market is segmented into polymerase chain reaction (PCR), enzyme-linked immunosorbent assay (ELISA), rapid diagnostic tests (RDT), and other nucleic acid amplification technology (INAAT). PCR accounted for the largest share of the global market in 2017. This segment is expected to grow at a CAGR of 8% from 2018 to 2030 due to its high accuracy and speed. ELISA held second largest share in 2017 owing to its low cost and easy availability. However, RDTs are projected to grow at highest CAGR during forecast period as they are portable, easy-to-use devices that provide results within minutes. Based on application, hospitals accounted for majority share of global hepatitis test solution market in 2017 followed by diagnostic laboratories . Hospitals are increasingly adopting point-of-care testing solutions for early diagnosis and treatment planning thereby driving demand for hepatitis tests . Nursing homes are also anticipated witness significant growth during forecast period as patients admitted in these facilities often suffer from chronic liver diseases caused by viral infections such as HCV or HBV .
Product Definition:
A hepatitis test solution is a medical diagnostic tool used to detect the presence of the hepatitis virus in a person's bloodstream. The solution is made up of antibodies that bind to the virus, making it visible under a microscope. The test is important for diagnosing and treating hepatitis infections.
Polymerase Chain Reaction (PCR):
Polymerase chain reaction (PCR) is a technique that uses repeated amplification of specific DNA sequences to provide information about the genetic structure of an infectious agent, viral or bacterial. The method is widely used in molecular diagnostics for the detection and identification of pathogens, particularly in samples where conventional testing procedures are complicated or impossible.
Enzyme-Linked Immunosorbent Assay (ELISA):
An enzyme-linked immunosorbent assay (ELISA) is a procedure to detect the presence of an antibody in the human body. It is used for detecting and measuring antibodies in various types of blood tests.
Application Insights:
Based on application, the market is segmented into hospitals, diagnostic laboratories, and others. Hospitals were the largest revenue generating centers in 2017 owing to factors such as a large patient base with high prevalence of chronic diseases and an increase in number of hospital-acquired infections. The majority of hepatitis cases are reported from North America and Europe which is expected to fuel product demand over the forecast period.
The other application segment includes commercial facilities such as blood banks that perform fewer tests compared to hospitals or laboratories due to low volume screening programs for infectious diseases. This segment accounted for a relatively smaller share in 2017 owing to low penetration rate coupled with technological limitations imposed by government regulations that restrict access only to accredited institutions/laboratories involved in disease diagnosis or testing activities relatedto hepatitis A & B viruses or antibody production against these viruses (in case of immunization).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of manufacturers, distributors, and end-users in this region. The U.S., which is one of the most developed countries with high healthcare expenditure and favorable reimbursement policies for technologically advanced products is expected to continue its dominance over the forecast period as well.
Growth Factors:
- Increasing incidence of hepatitis infections: The global incidence of hepatitis is increasing due to various factors such as changing lifestyles, growing population, and increasing travel. This is expected to drive the demand for hepatitis tests and solutions in the coming years.
- Growing awareness about hepatitis: There is a growing awareness about the different types of hepatitis and their symptoms among people around the world. This is likely to increase the demand for diagnostic tests and solutions for hepatits in the near future.
- Technological advancements: The development of new technologies has led to better detection methods for hepatits, which is expected to boost the market growth in coming years.
- Rising number of patients with chronic liver diseases: The number of patients with chronic liver diseases such as cirrhosis and hepatocellular carcinoma (HCC) are on rise globally due to various reasons such as unhealthy lifestyle habits, alcohol consumption, etc.. This is anticipated to create a high demand for effective treatment options including diagnosis and therapy services thereby propelling market growth over forecast period . 5 Emerging economies offer lucrative opportunities: A large population base coupled with rising income levels offers significant potential growth opportunities for players operating in this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis Test Solution Market Research Report
By Type
Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), IsOthersmal Nucleic Acid Amplification Technology (INAAT), Others Technologies
By Application
Hospitals, Diagnostic Laboratories, Nursing Homes, Blood Banks, Others
By Companies
Roche, Abbott, DiaSorin, Bio-Rad, Siemens, QIAGEN, bioMérieux, Grifols, Danaher
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis Test Solution Market Report Segments:
The global Hepatitis Test Solution market is segmented on the basis of:
Types
Polymerase Chain Reaction (PCR), Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests (RDT), IsOthersmal Nucleic Acid Amplification Technology (INAAT), Others Technologies
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Laboratories, Nursing Homes, Blood Banks, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Abbott
- DiaSorin
- Bio-Rad
- Siemens
- QIAGEN
- bioMérieux
- Grifols
- Danaher
Highlights of The Hepatitis Test Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Rapid Diagnostic Tests (RDT)
- IsOthersmal Nucleic Acid Amplification Technology (INAAT)
- Others Technologies
- By Application:
- Hospitals
- Diagnostic Laboratories
- Nursing Homes
- Blood Banks
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis Test Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hepatitis Test Solution is a homeopathic remedy that is used to treat hepatitis.
Some of the major players in the hepatitis test solution market are Roche, Abbott, DiaSorin, Bio-Rad, Siemens, QIAGEN, bioMƒÂ©rieux, Grifols, Danaher.
The hepatitis test solution market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hepatitis Test Solution Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hepatitis Test Solution Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hepatitis Test Solution Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hepatitis Test Solution Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hepatitis Test Solution Market Size & Forecast, 2018-2028
4.5.1 Hepatitis Test Solution Market Size and Y-o-Y Growth
4.5.2 Hepatitis Test Solution Market Absolute $ Opportunity
Chapter 5 Global Hepatitis Test Solution Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hepatitis Test Solution Market Size Forecast by Type
5.2.1 Polymerase Chain Reaction (PCR)
5.2.2 Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.3 Rapid Diagnostic Tests (RDT)
5.2.4 IsOthersmal Nucleic Acid Amplification Technology (INAAT)
5.2.5 Others Technologies
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hepatitis Test Solution Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hepatitis Test Solution Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Laboratories
6.2.3 Nursing Homes
6.2.4 Blood Banks
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hepatitis Test Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hepatitis Test Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hepatitis Test Solution Analysis and Forecast
9.1 Introduction
9.2 North America Hepatitis Test Solution Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hepatitis Test Solution Market Size Forecast by Type
9.6.1 Polymerase Chain Reaction (PCR)
9.6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
9.6.3 Rapid Diagnostic Tests (RDT)
9.6.4 IsOthersmal Nucleic Acid Amplification Technology (INAAT)
9.6.5 Others Technologies
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hepatitis Test Solution Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Laboratories
9.10.3 Nursing Homes
9.10.4 Blood Banks
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hepatitis Test Solution Analysis and Forecast
10.1 Introduction
10.2 Europe Hepatitis Test Solution Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hepatitis Test Solution Market Size Forecast by Type
10.6.1 Polymerase Chain Reaction (PCR)
10.6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
10.6.3 Rapid Diagnostic Tests (RDT)
10.6.4 IsOthersmal Nucleic Acid Amplification Technology (INAAT)
10.6.5 Others Technologies
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hepatitis Test Solution Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Laboratories
10.10.3 Nursing Homes
10.10.4 Blood Banks
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hepatitis Test Solution Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hepatitis Test Solution Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hepatitis Test Solution Market Size Forecast by Type
11.6.1 Polymerase Chain Reaction (PCR)
11.6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
11.6.3 Rapid Diagnostic Tests (RDT)
11.6.4 IsOthersmal Nucleic Acid Amplification Technology (INAAT)
11.6.5 Others Technologies
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hepatitis Test Solution Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Laboratories
11.10.3 Nursing Homes
11.10.4 Blood Banks
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hepatitis Test Solution Analysis and Forecast
12.1 Introduction
12.2 Latin America Hepatitis Test Solution Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hepatitis Test Solution Market Size Forecast by Type
12.6.1 Polymerase Chain Reaction (PCR)
12.6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
12.6.3 Rapid Diagnostic Tests (RDT)
12.6.4 IsOthersmal Nucleic Acid Amplification Technology (INAAT)
12.6.5 Others Technologies
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hepatitis Test Solution Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Laboratories
12.10.3 Nursing Homes
12.10.4 Blood Banks
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hepatitis Test Solution Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hepatitis Test Solution Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hepatitis Test Solution Market Size Forecast by Type
13.6.1 Polymerase Chain Reaction (PCR)
13.6.2 Enzyme-Linked Immunosorbent Assay (ELISA)
13.6.3 Rapid Diagnostic Tests (RDT)
13.6.4 IsOthersmal Nucleic Acid Amplification Technology (INAAT)
13.6.5 Others Technologies
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hepatitis Test Solution Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Laboratories
13.10.3 Nursing Homes
13.10.4 Blood Banks
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hepatitis Test Solution Market: Competitive Dashboard
14.2 Global Hepatitis Test Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 Abbott
14.3.3 DiaSorin
14.3.4 Bio-Rad
14.3.5 Siemens
14.3.6 QIAGEN
14.3.7 bioMérieux
14.3.8 Grifols
14.3.9 Danaher
